Kane Biotech Inc V.KNE

Alternate Symbol(s): KNBIF

Healthcare Biotechnology

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.

TSXV:KNE - Post by User

Kane Biotech Inc

Bullboard Posts

Comment by CurlyMickon Apr 03, 2014 5:45pm

100 Views

Post# 22408474

RE:RE:RE:RE:RE:Could This Be?

Thanks for the vote of confidence....lol. Regardless, any (all) of us here using Stockhouse are all just doing the best that we can with the info we have. I think the Burconfan guy is just another hopeful speculator.

On another note; TWD opens at 8am tomorrow. The first medical marijuana company listed in Canada.

Go Tweed Go!

Yes, that is shameless pumping.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario